ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
119.805,67
1,07%
S&P 500
5.991,13
0,82%
US Dollar vs BRL
6,1425
-0,64%
Bitcoin
98.982,64
0,67%
Brent Oil
76,905
0,52%
As Melhores Corretoras Online
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Xenetic Biosciences Inc (XBIO)

  7. Xenetic Biosciences Inc (XBIO) Notícias

XBIO

Xenetic Biosciences (XBIO)

Xenetic Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:XBIO
DataHoraFonteTítuloCódigoCompanhia
13/12/202419:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
13/12/202418:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XBIOXenetic Biosciences Inc
04/11/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XBIOXenetic Biosciences Inc
31/10/202417:50Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:XBIOXenetic Biosciences Inc
31/10/202417:40Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:XBIOXenetic Biosciences Inc
31/10/202417:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:XBIOXenetic Biosciences Inc
21/10/202418:00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:XBIOXenetic Biosciences Inc
13/08/202417:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XBIOXenetic Biosciences Inc
18/12/202319:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
18/09/202313:21Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:XBIOXenetic Biosciences Inc
15/06/202318:21Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:XBIOXenetic Biosciences Inc
02/06/202309:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XBIOXenetic Biosciences Inc
11/05/202317:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XBIOXenetic Biosciences Inc
22/03/202317:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XBIOXenetic Biosciences Inc
09/12/202219:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XBIOXenetic Biosciences Inc
10/11/202211:35TipRanksH.C. Wainwright Keeps Their Buy Rating on Xenetic Biosciences (XBIO)NASDAQ:XBIOXenetic Biosciences Inc
21/10/202217:21Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XBIOXenetic Biosciences Inc
17/10/202218:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XBIOXenetic Biosciences Inc
03/10/202218:13Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:XBIOXenetic Biosciences Inc
13/05/202207:36TipRanksXenetic Biosciences (XBIO) Gets a Buy Rating from H.C. WainwrightNASDAQ:XBIOXenetic Biosciences Inc
02/05/202207:17TipRanksH.C. Wainwright Maintains Their Buy Rating on Xenetic Biosciences (XBIO)NASDAQ:XBIOXenetic Biosciences Inc
28/04/202217:33Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:XBIOXenetic Biosciences Inc
28/04/202207:25TipRanksH.C. Wainwright Thinks Xenetic Biosciences’ Stock is Going to RecoverNASDAQ:XBIOXenetic Biosciences Inc
30/12/202118:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XBIOXenetic Biosciences Inc
19/11/202118:55Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:XBIOXenetic Biosciences Inc
25/10/202107:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:XBIOXenetic Biosciences Inc
20/10/202117:31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:XBIOXenetic Biosciences Inc
15/10/202118:00Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:XBIOXenetic Biosciences Inc
12/10/202118:25Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:XBIOXenetic Biosciences Inc
23/10/201917:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XBIOXenetic Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:XBIO

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
PRIO3
PETRORIO ON
BOV
GOLL4
GOL PN
BOV
AZEV3
AZEVEDO ON
BOV
GFSA3
GAFISA ON
BOV
BRAV3
Brava Energia ON
BOV
TELB4
TELEBRAS PN
BOV
BEEF3
MINERVA ON
BOV
RAIZ4
Raizen S.A PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados